| CAS ID: | 26787-78-0 |
| Molecular Formula: | C16H19N3O5S |
| Molecular Weight: | 365.4 g/mol |
| Monoisotopic Mass: | 365.1045 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | AMOPEN | AMOXYMED | AMOXIL SF | AMOXIL | AMIX 500 | UTIMOX | TRIMOX | RESPILLIN | MOXATAG | Biomox | BRL 2333 | AMRIT | AMOXIL FIZTAB | AMORAM | AMIX 250 | BRL-2333AB-B | DISPERMOX | AMOXICILLIN PEDIATRIC | AMOXICILLIN SODIUM | Sumox | Robamox | POLYMOX | Amoxycillin | Amoxi-Inject | AMOXIDENT 500 | LAROTID | FLEMOXIN SOLUTAB | Amoxi-Tabs | AMIX 125 | Amoxicilline | ZOXYCIL 250 | Aquacil | WYMOX | Vetremox | GALENAMOX | AMOXIDENT 250 | AMOXICILLIN | ZOXYCIL 500 | DEDOXIL |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C16H19N3O5S/c1-16(2)11(15(23)24)19-13(22)10(14(19)25-16)18-12(21)9(17)7-3-5-8(20)6-4-7/h3-6,9-11,14,20H,17H2,1-2H3,(H,18,21)(H,23,24)/t9-,10-,11+,14-/m1/s1 | See All |
| InChI Key: | LSQZJLSUYDQPKJ-NJBDSQKTSA-N | |
| Smiles: | CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT01820026 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Unknown |
| First Received | March 28, 2013 | Last Verified | May 29, 2015 |
| Sponsor | University of Roma La Sapienza | ||
| PubChem: | 33613 |
| ChEMBL: | CHEMBL1082 |